Navigation Links
Howard Dean to Speak at the 2010 DTC National Conference
Date:2/10/2010

Dean scheduled to deliver keynote speech on April 7, 2010 at the J.W. Marriott Hotel in Washington D.C.

Florham Park, N.J. (PRWEB) February 10, 2010 -- DTC Perspectives, Inc., the leading conference, training and publishing company for direct-to-consumer (DTC) marketing, is proud to announce that former Vermont Governor and licensed medical doctor Howard Dean will act as a keynote speaker at the 2010 DTC National Conference to be held April 7-9 at the J.W. Marriott Hotel in Washington D.C. Dean will address the conference delegates on day one of the event (Apr. 7) by posing the question, “What is Real Healthcare Reform?” Interested parties can register for the conference at www.DTCPerspectives.com.

Former Vermont Governor Howard Dean founded Democracy for America (DFA) in 2004 to build on the grassroots momentum for reform that his bid for the presidency sparked in 2004. The movement propelled DFA into a successful national organization committed to the "50 State Strategy" with more than 1 million members. In 2005, Governor Dean was elected to chair the Democratic National Committee (DNC) and from 2005–2009 he spearheaded the DNC's support of the Democratic Party, setting up Democrats to take back Congress in 2006 and win the White House in 2008. Upon leaving the DNC early last year, Governor Dean has returned to DFA as a senior adviser on the issue of healthcare and he has become a leading commentator on the various reform proposals that moved through Congress in 2009.

Additional keynote speakers scheduled to appear at the 2010 conference include global industry leaders Steve Case, founder of AOL, and Amy Cowan, Head of Industry, Google; Pharmaceutical marketers Tom Curatolo, Product Director, Vyvanse Marketing, Shire U.S., Inc., Tim Gamble, Global Market Analytics, Pfizer Inc., Sam Trujillo, Director of Consumer Marketing, Bayer HealthCare Pharmaceuticals, Paul Stevenson, Senior Product Manager, Novo Nordisk, and Richard Baron, Executive Director of Customer Development Marketing, Boehringer Ingelheim.

The DTC National Conference is designed to provide DTC marketers with an opportunity to learn from industry thought leaders and discuss the latest innovations in DTC marketing. Over the three day conference, the more than 550 attendees benefit from case studies, new market research, media & marketing gurus and networking opportunities. Attendance is recommended for all industry members, including pharmaceutical brand team members, agency executives, media buyers and planners, market researchers, media partners and solution providers.

For more information on the 2010 DTC National Conference Agenda or for conference registration, please visit our Website, www.DTCperspectives.com or call Debra Sander at (973) 377-2106 ex 221.

DTC Perspectives, Inc. is a conference, training and publishing company that specializes in the analysis of pharmaceutical product consumer marketing. It is our goal to serve as the premier information exchange forum for DTC marketers with the publication of DTC Perspectives magazine as well as through attendance at our highly respected DTC Conference Series.


###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3581444.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Excerpts from DNC Chairman Howard Deans Remarks at the National Baptist Convention
2. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
3. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Micrus Endovascular Corporation
4. UT Southwestern researcher named Howard Hughes Medical Institute investigator
5. CVS Caremarks Howard McLure Elected New PCMA Board Chairman
6. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against WellCare Health Plans, Inc.
7. Law Offices of Howard G. Smith Announces 14 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Care Investment Trust Inc.
8. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Micrus Endovascular Corporation
9. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Security Capital Assurance Ltd.
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Howard Dean to Speak at the 2010 DTC National Conference 
(Date:2/21/2017)... ... February 21, 2017 , ... ... Philpart, senior director at PolicyLink, will be the keynote speaker at its second ... and Men of Color Framework, which develops comprehensive strategies to create and expand ...
(Date:2/21/2017)... ... February 21, 2017 , ... Support of value-based care ... the secure exchange of data across industry solutions, Fogo Data Centers announces the launch ... community. A healthy community is one in which all systems work well, work ...
(Date:2/21/2017)... ... February 21, 2017 , ... HIMSS is ... connected care demonstration spanned multiple health information systems including OpenEMR, EMRDirect, and ... providers have no Health Information Exchange outside of faxing. Medal’s innovative technology “meets ...
(Date:2/20/2017)... ... February 20, 2017 , ... A new digital ... are called back for additional examinations without sacrificing cancer detection, according to a ... the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for use ...
(Date:2/20/2017)... ... February 20, 2017 , ... Scrubbing in for his first ... Dr. Christopher Pezzi remembers the excitement of the surgeon training him. , “He was ... to do this? Don’t tell anyone, but I would do it for free,’” Dr. ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Feb. 21, 2017  International Isotopes Inc. (OTCQB: INIS) ... placement with certain investors for approximately $3.4 million of ... Series C Convertible Redeemable Preferred Stock (the "Series C ... annual rate of 6% and is convertible into common ... use the proceeds for operating capital, to pay off ...
(Date:2/21/2017)... , Feb. 21, 2017 Research and Markets ... Devices - Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a ...
(Date:2/21/2017)... 21, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Uterine cancer Drugs Price Analysis and Strategies ... cancer market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Uterine cancer ...
Breaking Medicine Technology: